IDiyas

For the Inventor, By the Inventor

Wilmington, DE, United States of America

G.d. Searle LLC


USPTO Granted Patents = 33


Trademarks = 15

Forward Citations = 179

Loading Chart...
Loading Chart...

90 inventors (with patents filed for the assignee):

goldMedal Daniel P Getman (14 out of 170 patents)

silverMedal John Nicholas Freskos (14 out of 126 patents)

bronzeMedal Gary A DeCrescenzo (13 out of 139 patents)

4.  John Jeffrey Talley (12 out of 227 patents)

5.  Michael L Vazquez (11 out of 131 patents)

6.  Richard A Mueller (9 out of 211 patents)

7.  James A Sikorski (8 out of 130 patents)

8.  Robert M Heintz (6 out of 56 patents)

9.  Deborah E Bertenshaw (6 out of 32 patents)

10.  Kevin C Glenn (6 out of 18 patents)

11.  Joseph J McDonald (4 out of 53 patents)

12.  Srinivasan Raj Nagarajan (3 out of 52 patents)

13.  Bradley T Keller (2 out of 11 patents)

14.  Daniel Paul Becker (2 out of 59 patents)

15.  Balekudru Devadas (2 out of 68 patents)


33 patents:

1. RE44048 - 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-YL]benzenesulfonamide for the treatment of inflammation or an inflammation-associated disorder (2013-03-04),
2. RE43802 - α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors (2012-11-12),
3. RE43596 - α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors (2012-08-20),
4. RE42889 - α- and β- amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors (2011-10-31),
5. 7829564 - α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors (2010-11-09),
6. 7531538 - α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors (2009-05-12),
7. 7339078 - Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors (2008-03-04),
8. 7320983 - α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors (2008-01-22),
9. 7297793 - Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors (2007-11-20),
10. 7226932 - Self-emulsifying drug delivery system (2007-06-05),
11. 7226757 - Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor (2007-06-05),
12. 7157101 - Micronized eplerenone compositions (2007-01-02),
13. 7132437 - Renal-selective biphenylalkyl 1H-substituted-1,2,4-triazole angiotensin II antagonists for treatment of hypertension (2006-11-07),
14. 7022672 - Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor (2006-04-04),
15. 7012094 - Substituted furans and furanones for the treatment of inflammation (2006-03-14),
G.D. Searle LLC is a pharmaceutical company that specializes in developing and manufacturing innovative healthcare products. With a focus on research and development, they create therapies for a wide range of medical conditions. Searle aims to improve patient well-being by delivering high-quality, effective, and safe medications. Their commitment to scientific advancement and dedication to the well-being of patients drives their work and ensures they contribute to the development of healthcare globally.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

33 Patents

#139 in Wilmington, DE

#175 in Delaware

#9,940 in US

#19,529 in the World

...
Wilmington, DE, United States of America

G.d. Searle LLC

Forward Citations = 179

90 inventors:

goldMedal Daniel P Getman (14 out of 170 patents)

silverMedal John Nicholas Freskos (14 out of 126 patents)

bronzeMedal Gary A DeCrescenzo (13 out of 139 patents)

4.  John Jeffrey Talley (12 out of 227 patents)

5.  Michael L Vazquez (11 out of 131 patents)

Please report any incorrect information to support@idiyas.com
Loading…